REPORTING REQUIREMENTS.

Tex. HEALTH & SAFETY Code § 491.059.
in effect
Sign in to generate a plain English summaryAsk Belisarius Agent
(a) A consortium selected to conduct ibogaine drug development clinical trials shall quarterly prepare and submit to the commission: (1) a report on the progress of the drug development clinical trials conducted under this subchapter; and (2) a financial status report, including information to verify expenditures of state funds and required matching funds. (b) The commission shall submit a report to the legislature on the progress of the drug development clinical trials conducted under this subchapter not later than December 1 of each year. Added by Acts 2025, 89th Leg., R.S., Ch. 333 (S.B. 2308 ), Sec. 1, eff. June 11, 2025.
Source: TX Statutes (Official Site)URL: https://statutes.capitol.texas.gov/Fetched: 6/29/2026

Starting a business in Texas? Texas LLC guide: costs and requirements